FDA Regulation of Biosimilars
Year of publication: |
2015
|
---|---|
Authors: | Lietzan, Erika |
Other Persons: | Grabowski, Henry G. (contributor) |
Publisher: |
[2015]: [S.l.] : SSRN |
Subject: | Regulierung | Regulation | Arzneimittel | Pharmaceuticals | Arzneimittelrecht | Pharmaceutical law | Pharmaindustrie | Pharmaceutical industry |
Description of contents: | Abstract [papers.ssrn.com] |
Extent: | 1 Online-Ressource |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: FDA in the Twenty First Century: The Challenges of Regulating Drugs and New Technologies (Columbia University Press 2015) Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments September 16, 2015 erstellt Volltext nicht verfügbar |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Regulation and drug development
Wardell, William M., (1975)
-
Chou, Yu-Wen, (2008)
-
Policy process lessons from the Orphan Drug Act : applications for health policy advocates
Andraka-Christou, Barbara, (2015)
- More ...
-
Special issue: Pharmaceutical economics : essays in honor of Henry G. Grabowski
Mullins, C. Daniel, (2011)
-
Lietzan, Erika, (2017)
-
Brief of 11 Professors as Amici Curiae in Support of Amgen in Amgen v. Sandoz
Lietzan, Erika, (2017)
- More ...